Characterization of rhodanine derivatives as potential disease-modifying drugs for experimental mouse osteoarthritis
Under an Elsevier user license
open archive
Keywords
Osteoarthritis
Posttraumatic OA
Mouse
Chondrocytes
Rhodanine-derived compounds
Disease-modifying OA drug (DMOAD)
Therapeutics
Cited by (0)
- a
These authors contributed equally to this work.
© 2022 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.